The company's neuro-marker powered platform has a significant impact on cognitive impairment treatments, validated by numerous patient cases in clinical settings worldwide. Their digital platform utilizes BEI technology to measure attention levels during cognitive exercises, providing an easy-to-use solution for objective measurement compared to current approaches. Brainmarc's platform is clinically proven to treat various cognitive deficiency conditions, including Post Stroke, TBI, and MCI, improving clinical outcomes both in clinics and at home.